ergocalciferol liquid
virtus pharmaceuticals - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 0.2 mg in 1 ml - contraindicated in people with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d- ergocalciferol capsule
aidarex pharmaceuticals llc - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d- ergocalciferol capsule
aphena pharma solutions - tennessee, llc - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d- ergocalciferol capsule
preferred pharmaceuticals, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d- ergocalciferol capsule
bryant ranch prepack - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
calcium with vitamins c and d tab tablet
pure life international prods inc. - calcium (calcium carbonate); ascorbic acid; vitamin d2 - tablet - 500mg; 10mg; 200unit - calcium (calcium carbonate) 500mg; ascorbic acid 10mg; vitamin d2 200unit - vitamins & minerals
liquid calcium with vitamin d capsule
t & t nutrition inc. - vitamin d (cholecalciferol); calcium (calcium phosphate, calcium citrate, calcium gluconate, calcium hvp chelate) - capsule - 100unit; 250mg - vitamin d (cholecalciferol) 100unit; calcium (calcium phosphate, calcium citrate, calcium gluconate, calcium hvp chelate) 250mg
calcium magnesium 2:1 tablets with vitamin d
sisu inc. - calcium (calcium citrate); magnesium (magnesium oxide); vitamin d2 (ergocalciferol) - tablet - 300mg; 150mg; 200unit - calcium (calcium citrate) 300mg; magnesium (magnesium oxide) 150mg; vitamin d2 (ergocalciferol) 200unit - vitamins & minerals
calcium folic acid plus d chewable- cholecalciferol, magnesium, boron, folic acid, pyridoxine, cyanocobalamin wafer
acella pharmaceuticals, llc - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), boron (unii: n9e3x5056q) (boron - unii:n9e3x5056q), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - calcium carbonate 1342 mg - indications and usage: calcium-folic acid plus d chewable wafers are indicated, in addition to diet, to help satisfy the distinctive nutritional requirements of individuals under the supervision of a physician for the treatment of calcium deficiency, skeletal weakness and osteoporosis. calcium-folic acid plus d chewable wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients contained therein. calcium and vitamin d supplementation may be useful in both preventing and treating osteoporosis. vitamin d supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. folic acid, vitamin b 6 , and vitamin b 12 , may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine. if dietary intake of calcium is inadequate, patients currently taking bisphosphonates for treatment of osteoporosis should be instructed to take calcium and vitamin d daily (calcium-folic
2% calcium gluconate in sodium chloride injection solution
fresenius kabi canada ltd - calcium gluconate - solution - 20mg - calcium gluconate 20mg